Esophageal and Gastroesophageal Junction Carcinoma

Observed

← altered in cohorts of

EFR3A

133 / 185 cases (72 %) · ssm · TCGA-ESCA

—

Observed

← altered in cohorts of

HHLA1

132 / 185 cases (71 %) · ssm · TCGA-ESCA

—

Observed

← altered in cohorts of

KHDRBS3

132 / 185 cases (71 %) · ssm · TCGA-ESCA

—

Observed

← altered in cohorts of

LRRC6

132 / 185 cases (71 %) · ssm · TCGA-ESCA

—

Observed

← altered in cohorts of

NDRG1

132 / 185 cases (71 %) · ssm · TCGA-ESCA

—

Observed

← altered in cohorts of

OC90

132 / 185 cases (71 %) · ssm · TCGA-ESCA

—

Observed

← altered in cohorts of

SLA

132 / 185 cases (71 %) · ssm · TCGA-ESCA

—

Observed

← altered in cohorts of

ZFAT

132 / 185 cases (71 %) · ssm · TCGA-ESCA

—

Observed

← altered in cohorts of

PHF20L1

131 / 185 cases (71 %) · ssm · TCGA-ESCA

—

Observed

← altered in cohorts of

ST3GAL1

131 / 185 cases (71 %) · ssm · TCGA-ESCA

—

Observed

← altered in cohorts of

TMEM71

131 / 185 cases (71 %) · ssm · TCGA-ESCA

—

Observed

← altered in cohorts of

ACTRT3

130 / 185 cases (70 %) · ssm · TCGA-ESCA

—

Observed

← altered in cohorts of

BCHE

130 / 185 cases (70 %) · ssm · TCGA-ESCA

—

Observed

← altered in cohorts of

LRRC31

130 / 185 cases (70 %) · ssm · TCGA-ESCA

—

Observed

Esophageal and Gastroesophageal Junction Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived144 of 144show fewer
→ investigated in trials for	Fluorouracilsmall molecule 98 trials (41 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	98	Observed	clinicaltrials	graph →
→ investigated in trials for	Oxaliplatinsmall molecule 96 trials (45 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	96	Observed	clinicaltrials	graph →
→ investigated in trials for	Paclitaxelsmall molecule 96 trials (44 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	96	Observed	clinicaltrials	graph →
→ investigated in trials for	Cisplatinsmall molecule 80 trials (28 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	80	Observed	clinicaltrials	graph →
→ investigated in trials for	Pembrolizumabmonoclonal antibody 76 trials (26 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	76	Observed	clinicaltrials	graph →
→ investigated in trials for	Capecitabinesmall molecule 66 trials (32 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	66	Observed	clinicaltrials	graph →
→ investigated in trials for	Docetaxelsmall molecule 52 trials (20 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	52	Observed	clinicaltrials	graph →
→ investigated in trials for	Irinotecansmall molecule 48 trials (15 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	48	Observed	clinicaltrials	graph →
→ investigated in trials for	Leucovorinsmall molecule 48 trials (22 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	48	Observed	clinicaltrials	graph →
→ investigated in trials for	Nivolumabmonoclonal antibody 38 trials (20 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	38	Observed	clinicaltrials	graph →
→ investigated in trials for	Carboplatinsmall molecule 36 trials (19 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	36	Observed	clinicaltrials	graph →
→ investigated in trials for	Tislelizumabmonoclonal antibody 35 trials (21 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	35	Observed	clinicaltrials	graph →
→ investigated in trials for	Trastuzumabmonoclonal antibody 30 trials (17 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	30	Observed	clinicaltrials	graph →
→ investigated in trials for	Ramucirumabmonoclonal antibody 27 trials (10 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	27	Observed	clinicaltrials	graph →
→ investigated in trials for	Toripalimabmonoclonal antibody 27 trials (14 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	27	Observed	clinicaltrials	graph →
→ investigated in trials for	Nab-paclitaxel 24 trials (11 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	24	Observed	clinicaltrials	graph →
→ investigated in trials for	Chemotherapy 23 trials (15 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	23	Observed	clinicaltrials	graph →
→ investigated in trials for	Camrelizumabmonoclonal antibody 21 trials (6 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	21	Observed	clinicaltrials	graph →
→ investigated in trials for	Sintilimabmonoclonal antibody 18 trials (9 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	18	Observed	clinicaltrials	graph →
→ investigated in trials for	Durvalumabmonoclonal antibody 16 trials (6 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	16	Observed	clinicaltrials	graph →
→ investigated in trials for	Cetuximabmonoclonal antibody 12 trials (3 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	12	Observed	clinicaltrials	graph →
→ investigated in trials for	Nimotuzumabmonoclonal antibody 12 trials (3 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	12	Observed	clinicaltrials	graph →
→ investigated in trials for	Adebrelimabmonoclonal antibody 11 trials (9 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	11	Observed	clinicaltrials	graph →
→ investigated in trials for	Bevacizumabmonoclonal antibody 9 trials (5 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Cyclophosphamidesmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Ipilimumabmonoclonal antibody 8 trials (4 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Serplulimabmonoclonal antibody 8 trials (8 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Atezolizumabmonoclonal antibody 7 trials (4 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Disitamab Vedotinadc 7 trials (6 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	7	Observed	clinicaltrials	graph →
→ investigated in trials for	FOLFOX Regimen 7 trials (4 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Lenvatinibsmall molecule 7 trials (5 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Tremelimumabmonoclonal antibody 7 trials (3 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Afatinibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Fludarabinesmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Carboplatin/Paclitaxel Regimen 5 trials (3 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Immunotherapy 5 trials (5 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Levoleucovorinsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Nedaplatinsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Avelumabmonoclonal antibody 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Gemcitabinesmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Lapatinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Tegafursmall molecule 4 trials (4 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Tucatinibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Zanidatamabmonoclonal antibody 4 trials (4 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Anti-PD1 Monoclonal Antibody 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Cabozantinibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Epirubicinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Hyperthermic Intraperitoneal Chemotherapy 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Niraparibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Palbociclibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Panitumumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Sunitinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Abemaciclibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Adavosertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Akt Inhibitor MK2206 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Aldesleukinother 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Catumaxomabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Dexamethasonesmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Dostarlimabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Doxorubicinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Elimusertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Erlotinib Hydrochloridesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Everolimussmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Fulvestrantsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Futibatinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Icotinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Infigratinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Mitomycinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Nintedanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Olaparibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Osimertinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Paclitaxel Liposome 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Pertuzumabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Pralatrexatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Raltitrexedsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Regorafenibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Retifanlimabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Ribociclibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Rucaparibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Sacituzumab Govitecanadc 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Trastuzumab Emtansineadc 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Vandetanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Veliparibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Vismodegibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Adjuvant Chemotherapy 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Alpelisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Alvocidibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Arsenic Trioxidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Aspirinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Berzosertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Binimetinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Bortezomibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Brentuximab Vedotinadc 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Cabazitaxelsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Capivasertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	CAPOX Regimen 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Carboplatin OR Cisplatin 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Celecoxibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Ceritinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Cixutumumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Copanlisibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Crizotinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Dabrafenibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Dasatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Decitabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Derazantinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Erdafitinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Eribulinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Erlotinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Etoposidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Fexagratinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	FOLFIRI Regimen 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	FOLFOX-6 Regimen 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Ganetespibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Hydroxychloroquinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Ibrutinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Ipatasertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Larotrectinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Margetuximabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Metforminsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	PD1 Inhibitor 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Pemetrexedsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Pertuzumab/Trastuzumab Regimen 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Porcupine Inhibitor WNT974 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Pyrotinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Rigosertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Rilotumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Rituximabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Romidepsinother 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Sapanisertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Savolitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Sirolimussmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Sonidegibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Sorafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Talazoparibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Taselisibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Temozolomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Thalidomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Trametinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Trastuzumab Deruxtecanadc 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Trastuzumab Deruxtecan Regimen 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Vinorelbinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Zolbetuximabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Zongertinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Esophageal and Gastroesophageal Junction Carcinoma	1	Observed	clinicaltrials	graph →

Esophageal and Gastroesophageal Junction Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived144 of 144show fewer

→ investigated in trials for

Fluorouracilsmall molecule

98 trials (41 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Oxaliplatinsmall molecule

96 trials (45 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Paclitaxelsmall molecule

96 trials (44 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cisplatinsmall molecule

80 trials (28 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pembrolizumabmonoclonal antibody

76 trials (26 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Capecitabinesmall molecule

66 trials (32 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Docetaxelsmall molecule

52 trials (20 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Irinotecansmall molecule

48 trials (15 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Leucovorinsmall molecule

48 trials (22 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nivolumabmonoclonal antibody

38 trials (20 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Carboplatinsmall molecule

36 trials (19 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tislelizumabmonoclonal antibody

35 trials (21 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Trastuzumabmonoclonal antibody

30 trials (17 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ramucirumabmonoclonal antibody

27 trials (10 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Toripalimabmonoclonal antibody

27 trials (14 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nab-paclitaxel

24 trials (11 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Chemotherapy

23 trials (15 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Camrelizumabmonoclonal antibody

21 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sintilimabmonoclonal antibody

18 trials (9 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Durvalumabmonoclonal antibody

16 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cetuximabmonoclonal antibody

12 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nimotuzumabmonoclonal antibody

12 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Adebrelimabmonoclonal antibody

11 trials (9 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bevacizumabmonoclonal antibody

9 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cyclophosphamidesmall molecule

9 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ipilimumabmonoclonal antibody

8 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Serplulimabmonoclonal antibody

8 trials (8 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Atezolizumabmonoclonal antibody

7 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Disitamab Vedotinadc

7 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

FOLFOX Regimen

7 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lenvatinibsmall molecule

7 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tremelimumabmonoclonal antibody

7 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Afatinibsmall molecule

6 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fludarabinesmall molecule

6 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

Carboplatin/Paclitaxel Regimen

→ investigated in trials for

5 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Immunotherapy

5 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Levoleucovorinsmall molecule

5 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nedaplatinsmall molecule

5 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Avelumabmonoclonal antibody

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Gemcitabinesmall molecule

4 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lapatinibsmall molecule

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tegafursmall molecule

4 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tucatinibsmall molecule

4 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Zanidatamabmonoclonal antibody

4 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

Anti-PD1 Monoclonal Antibody

→ investigated in trials for

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cabozantinibsmall molecule

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Epirubicinsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

Hyperthermic Intraperitoneal Chemotherapy

→ investigated in trials for

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Niraparibsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Palbociclibsmall molecule

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Panitumumabmonoclonal antibody

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sunitinibsmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Abemaciclibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Adavosertibsmall molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Akt Inhibitor MK2206

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Aldesleukinother

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Catumaxomabmonoclonal antibody

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dexamethasonesmall molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dostarlimabmonoclonal antibody

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Doxorubicinsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Elimusertibsmall molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Erlotinib Hydrochloridesmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Everolimussmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fulvestrantsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Futibatinibsmall molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Icotinibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Infigratinibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Mitomycinsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nintedanibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Olaparibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Osimertinibsmall molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Paclitaxel Liposome

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pertuzumabmonoclonal antibody

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pralatrexatesmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Raltitrexedsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Regorafenibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Retifanlimabmonoclonal antibody

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ribociclibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Rucaparibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sacituzumab Govitecanadc

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Trastuzumab Emtansineadc

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vandetanibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Veliparibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vismodegibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Adjuvant Chemotherapy

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alpelisibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alvocidibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Arsenic Trioxidesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Aspirinsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Berzosertibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Binimetinibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bortezomibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Brentuximab Vedotinadc

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cabazitaxelsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Capivasertibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

CAPOX Regimen

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Carboplatin OR Cisplatin

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Celecoxibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ceritinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cixutumumabmonoclonal antibody

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Copanlisibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Crizotinibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dabrafenibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dasatinibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Decitabinesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Derazantinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Erdafitinibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Eribulinsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Erlotinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Etoposidesmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fexagratinibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

FOLFIRI Regimen

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

FOLFOX-6 Regimen

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ganetespibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Hydroxychloroquinesmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ibrutinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ipatasertibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Larotrectinibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Margetuximabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Metforminsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

PD1 Inhibitor

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pemetrexedsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

Pertuzumab/Trastuzumab Regimen

→ investigated in trials for

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

Porcupine Inhibitor WNT974

→ investigated in trials for

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pyrotinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Rigosertibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Rilotumumabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Rituximabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Romidepsinother

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sapanisertibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Savolitinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sirolimussmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sonidegibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sorafenibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Talazoparibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Taselisibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Temozolomidesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Thalidomidesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Trametinibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Trastuzumab Deruxtecanadc

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

Trastuzumab Deruxtecan Regimen

→ investigated in trials for

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vinorelbinesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Zolbetuximabmonoclonal antibody

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Zongertinibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

Esophageal and Gastroesophageal Junction Carcinoma studied in …STUDIED_INderived10 of 1,309show all (up to 200)
→ studied in	NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active)	—	—	Esophageal Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06203600Phase 2/Phase 3 · recruiting Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active)	—	—	Esophageal Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07212491enrolling by invitation Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active)	—	—	Esophageal Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07529808Phase 1/Phase 2 · recruiting Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active)	—	—	Gastric Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07603375Phase 2 · recruiting Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active)	—	—	Esophageal Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03030404completed Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer · condition mapped ALIAS · 1,309 trials mapped (550 active)	—	—	Hereditary Gastric Diffuse Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05965999recruiting Lucid Registry Study · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active)	—	—	Esophageal Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07277413Phase 1 · recruiting A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active)	—	—	Gastric Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07392892Phase 2/Phase 3 · recruiting Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active)	—	—	Esophageal Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07733180Phase 2 · recruiting A Study Investigating Alternate Schedules of Tislelizumab Plus Chemotherapy in Japanese Patients With First-line Advanced ESCC · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active)	—	—	Esophageal Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →

Esophageal and Gastroesophageal Junction Carcinoma studied in …STUDIED_INderived10 of 1,309show all (up to 200)

→ studied in

NCT02465060Phase 2 · active not recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active)

—

Observed

→ studied in

NCT06203600Phase 2/Phase 3 · recruiting

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active)

—

Observed

→ studied in

NCT07212491enrolling by invitation

Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active)

—

Observed

→ studied in

NCT07529808Phase 1/Phase 2 · recruiting

Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active)

—

Gastric Adenocarcinoma

Observed

→ studied in

NCT07603375Phase 2 · recruiting

Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active)

—

Observed

Hereditary Gastric Diffuse Adenocarcinoma

→ studied in

NCT03030404completed

Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer · condition mapped ALIAS · 1,309 trials mapped (550 active)

—

Observed

→ studied in

NCT05965999recruiting

Lucid Registry Study · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active)

—

Observed

→ studied in

NCT07277413Phase 1 · recruiting

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active)

—

Gastric Adenocarcinoma

Observed

→ studied in

NCT07392892Phase 2/Phase 3 · recruiting

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active)

—

Observed

Esophageal Squamous Cell Carcinoma

→ studied in

NCT07733180Phase 2 · recruiting

A Study Investigating Alternate Schedules of Tislelizumab Plus Chemotherapy in Japanese Patients With First-line Advanced ESCC · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active)

—

Observed